| RS2524260150 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524260307 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524263141 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524263343 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2524264000 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2524267221 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524268975 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524271761 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524271890 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524273545 |
MUTYH
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2524273974 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524274573 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastric cancer |
| RS2524275031 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524276243 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524277188 |
GNAI3
|
Health Risk |
Likely pathogenic |
— |
| RS2524277212 |
GNAI3
|
Health Risk |
Likely pathogenic |
Auriculocondylar syndrome 1, Auriculocondylar syndrome 1 |
| RS2524279750 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2524280386 |
MYSM1
|
Health Risk |
Likely pathogenic |
Bone marrow failure syndrome 4, Bone marrow failure syndrome 4 |
| RS2524281792 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524282171 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524282719 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524283034 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524283273 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524283822 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524284138 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524284551 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2524285007 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524285018 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524285124 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524285749 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2524285979 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524286564 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524289902 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524295993 |
DNAJB4
|
Health Risk |
Pathogenic |
Congenital myopathy 21 with early respiratory failure, Congenital myopathy 21 with early respiratory failure |
| RS2524296398 |
DNAJB4
|
Health Risk |
Pathogenic |
Congenital myopathy 21 with early respiratory failure, Congenital myopathy 21 with early respiratory failure |
| RS2524299320 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524299345 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524299734 |
CDC14A
|
Health Risk |
Likely pathogenic |
— |
| RS2524305660 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524305677 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2524307697 |
COL4A5
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2524307924 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, Thyroid cancer |
| RS2524308059 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524308291 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524308395 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524308688 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524308731 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524308896 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524308940 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524309001 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524309012 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524313782 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524313994 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524314322 |
COL4A5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2524314385 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524314766 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524315244 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524322289 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS2524323517 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524323724 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524324196 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524325219 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524325278 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524325627 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524325659 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524325726 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524325761 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524325836 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524325926 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2524326032 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524326208 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524327169 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524328004 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524328425 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524328506 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524328561 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524328643 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524328741 |
COL4A5
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2524328750 |
COL4A5
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2524328777 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524328853 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524329089 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524330554 |
CDC14A
|
Health Risk |
Pathogenic |
— |
| RS2524330840 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2524331289 |
CLCNKA
|
Health Risk |
Likely pathogenic |
Bartter disease type 4B, Bartter disease type 4B |
| RS2524332896 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524332908 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524332992 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524333149 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524333211 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524333227 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524333986 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524335869 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524336523 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS2524338495 |
GNAT2
|
Health Risk |
Pathogenic |
— |
| RS2524338502 |
GNAT2
|
Health Risk |
Pathogenic |
— |
| RS2524344930 |
GNAT2
|
Health Risk |
Likely pathogenic |
— |
| RS2524346214 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524346601 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524347107 |
COL4A5
|
Health Risk |
Pathogenic |
— |